AMIX vs. PDEX, SEPA, NVNO, SRTS, ICCM, APYX, MGRM, BWAY, NSPR, and DXR
Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Pro-Dex (PDEX), SEP Acquisition (SEPA), enVVeno Medical (NVNO), Sensus Healthcare (SRTS), IceCure Medical (ICCM), Apyx Medical (APYX), Monogram Orthopaedics (MGRM), BrainsWay (BWAY), InspireMD (NSPR), and Daxor (DXR). These companies are all part of the "surgical & medical instruments" industry.
Autonomix Medical (NASDAQ:AMIX) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, community ranking, analyst recommendations and risk.
Pro-Dex has a net margin of 5.59% compared to Autonomix Medical's net margin of 0.00%. Pro-Dex's return on equity of 8.97% beat Autonomix Medical's return on equity.
Pro-Dex received 145 more outperform votes than Autonomix Medical when rated by MarketBeat users.
In the previous week, Pro-Dex had 1 more articles in the media than Autonomix Medical. MarketBeat recorded 2 mentions for Pro-Dex and 1 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 0.45 beat Pro-Dex's score of -0.14 indicating that Autonomix Medical is being referred to more favorably in the media.
Pro-Dex has higher revenue and earnings than Autonomix Medical.
10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 42.6% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Pro-Dex beats Autonomix Medical on 9 of the 10 factors compared between the two stocks.
Get Autonomix Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Autonomix Medical Competitors List
Related Companies and Tools
